Common treatments include R-CHOP and radiation therapy. If these treatments do not work well, it may be treated using different chemotherapy drugs, immunotherapy (CAR-T), or stem cell transplants.

Chronic lymphocytic leukemia (CLL) is a type of cancer affecting the bone marrow lymphocytes. It can affect B or T cells and may be slow- or fast-growing. CLL is a common type of leukemia ...

AFM28, a bispecific, tetravalent innate cell engager (ICE ®) targeting CD123 and CD16A, achieved a 40% composite complete remission rate (CRcR) at the highest dose level (300 mg) in heavily pretreated ...

Updated Results and Longer Follow-up from the AUGMENT-101 Phase 2 Study of Revumenib in All Patients with Relapsed or Refractory (R/R) KMT2Ar Acute Leukemia. Presented at: 2024 ASH Annual Meeting; ...

Teachey, MD, a study co-author, Chair of the Acute Lymphoblastic Leukemia Disease Committee in COG, and Director of Clinical Research at the Center for Childhood Cancer Research at CHOP. "Moving ...

America’s most popular dog toy this year has been “Lamb Chop,” a small plush lamb that millions of dog owners buy annually. The squeaky toy got its name from a puppet with curly hair that ...

Wear OS has come a long way from previous glitches and Google's indifference to its current evolution as a viable wearable operating system, opening things up to a range of models running Wear OS ...

Korneffel and his family lived in Colorado, but his parents brought him to CHOP for treatment, which included chemotherapy, full-body radiation, a bone marrow transplant and a partial splenectomy over ...

Harvey Weinstein was rushed back to Bellevue Hospital after receiving an "alarming blood test" as his rep confirmed the former film producer had been diagnosed with leukemia. "Harvey Weinstein ...

Ansari. His spokesperson, Juda Engelmayer, also confirmed that Weinstein had been diagnosed with leukemia, after prior news reports. “Mr. Weinstein, who is suffering from a number of illnesses ...

CAEBV, Chronic active Epstein-Barr Virus disease; NK, natural killer; modified CHOP, cyclophosphamide, pirarubicin ... At a median follow-up of 36 months, the 2-year PFS and OS rates were 33% and 72%, ...